Environmental, Social And Governance Report

Overview

The report presents Luye Pharma's fifth ESG disclosure for 2020, with the reporting scope expanded to include Boan Biotech. It describes a stakeholder-based materiality assessment and extensive policies covering environmental protection, occupational safety, product responsibility and employees. The company reports total energy consumption of 147,032.29 '000 kWh and a workforce of 4,980 employees, while highlighting ISO-certified environmental and occupational health and safety management systems.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2020
Period: 1 January 2020 – 31 December 2020
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services